Inovio Pharmaceuticals Says FDA Accepts Biologics License Application for INO-3107 for Standard Review; Shares Fall
Inovio Pharmaceuticals (INO) said Monday that the US Food and Drug Administration has accepted its b
Keep reading this article with Yahoo Finance Plus Silver
Silver
- Premium news Full access to Financial Times and MT Newswires articles
- Stock picks Expert picks from Motley Fool, Zacks, and Moby
- Research reports Expert analysis from Morningstar and Argus
